Patents by Inventor Stefan Kammers

Stefan Kammers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050192239
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: September 1, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun, Rikard Reneland
  • Publication number: 20050170500
    Abstract: Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more CDK10, FPGT, PCLO or REPS2 directed agents. These embodiments are based upon an analysis of polymorphic variations in a CDK10, FPGT, PCLO or REPS2 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1, 2, 3 or 4.
    Type: Application
    Filed: November 6, 2003
    Publication date: August 4, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun
  • Publication number: 20050118606
    Abstract: Provided herein are methods for identifying a risk of cancer in a subject and/or a subject at risk of cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating cancer, and therapeutic methods for treating cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in a KLF12 nucleic acid, which has a nucleotide sequence exemplified in SEQ ID NO: 1, 2 or 3.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 2, 2005
    Inventors: Richard Roth, Caridad Rosette, Mikhail Denissenko, Matthew Nelson, Rikard Reneland, Andreas Braun, Stefan Kammerer
  • Publication number: 20050118117
    Abstract: Provided herein are methods for identifying risk of melanoma in a subject and/or subjects at risk of melanoma, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, therapeutic methods for treating melanoma in a subject and compositions comprising one or more melanoma cells and one or more NRP1, NID2 or ENDO180 directed agents. These embodiments are based upon an analysis of polymorphic variations in a NRP1, NID2 or ENDO180 nucleic acid, exemplified by nucleotide sequences of SEQ ID NO: 1, 2 or 3.
    Type: Application
    Filed: November 6, 2003
    Publication date: June 2, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun
  • Publication number: 20050064440
    Abstract: Provided herein are methods for identifying a subject at risk of melanoma and risk of melanoma in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating melanoma, and therapeutic methods for treating melanoma in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 6, 2003
    Publication date: March 24, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun
  • Publication number: 20050064442
    Abstract: Provided herein are methods for identifying a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: March 24, 2005
    Inventors: Richard Roth, Josephine Atienza, Mikhail Denissenko, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland
  • Publication number: 20050053958
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: March 10, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun, Rikard Reneland